Ghent University Academic Bibliography

Journal Article

Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer : a multicenter, single-arm phase 2a study

Peter Hillemanns, Michal Zikan, Frédéric Forget, Hannelore Denys (UGent) , Jean-Francois Baurain, Lukas Rob, Linn Woelber, Pawel Blecharz, Mariusz Bidzinski, Josef Chovanec, et al.

(2025) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 13(1).

Add to list

Journal Article
A1
open access

Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models

Robbe Salembier (UGent) , Caro De Haes (UGent) , Julie Bellemans (UGent) , Kristel Demeyere (UGent) , Wim Van Den Broeck (UGent) , Niek Sanders (UGent) , Steven Van Laere, Traci R. Lyons, Evelyne Meyer (UGent) and Jonas Steenbrugge (UGent)

(2024) BREAST CANCER RESEARCH. 26(1).

Add to list

CD4+T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy

Amelie Franken, Michel Bila, Aurelie Mechels, Sam Kint (UGent) , Jeroen Van Dessel, Valentina Pomella, Sebastiaan Vanuytven, Gino Philips, Orian Bricard, Jieyi Xiong, et al.

(2024) IMMUNITY. 57(3). p.541-558.e7

Add to list

Journal Article
A1
open access

Lipid nanoparticle encapsulation empowers poly(I:C) to activate cytoplasmic RLRs and thereby increases its adjuvanticity

Alexander Lamoot, Sonia Jangra, Gabriel Laghlali, Prajakta Warang, Gagandeep Singh, Lauren A. Chang, Seok‐Chan Park, Gagandeep Singh, Kim Deswarte (UGent) , Zifu Zhong (UGent) , et al.

(2024) SMALL. 20(10).

Add to list

Journal Article
A1
open access

Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis : post hoc analysis of a large phase 3 trial

Oliver Pfaar, Frédéric De Blay, Giorgio Walter Canonica, Thomas B. Casale, Philippe Gevaert (UGent) , Peter Hellings (UGent) , Krzysztof Kowal, Giovanni Passalacqua, Miguel Tortajada-Girbés, Carmen Vidal, et al.

(2024) WORLD ALLERGY ORGANIZATION JOURNAL. 17(1).

Add to list

Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool

Yanou Engelen (UGent) , Dmitri Krysko (UGent) , Iuliia Efimova (UGent) , Karine Breckpot, Michel Versluis, Stefaan De Smedt (UGent) , Guillaume Lajoinie and Ine Lentacker (UGent)

(2024) JOURNAL OF CONTROLLED RELEASE. 375. p.389-403

Add to list

Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial

Emiel De Jaeghere (UGent) , Hannelore Hamerlinck (UGent) , Sandra Tuyaerts, Lien Lippens (UGent) , An M.T. Van Nuffel, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.

(2024) GYNECOLOGIC ONCOLOGY. 191. p.275-286

Add to list

Journal Article
A1
open access

International Consensus Statement on Allergy and Rhinology : Sinonasal Tumors

Edward C. Kuan, Eric W. Wang, Nithin D. Adappa, Daniel M. Beswick, Nyall R. London, Shirley Y. Su, Marilene B. Wang, Waleed M. Abuzeid, Borislav Alexiev, Jeremiah A. Alt, et al.

(2024) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 14(2). p.149-608

Add to list

Journal Article
A1
open access

Immunotherapy in elderly head and neck cancer patients : a systematic review and meta-analysis

Viola Salvestrini, Saverio Caini, Melissa Scricciolo, Michael Saerens (UGent) , Heleen Bollen, Pierluigi Bonomo, Francesca Caparrotti, Luigi Lorini, Marc Oliva, Maria Urbanowicz-Nijaki, et al.

(2024) FRONTIERS IN ONCOLOGY. 14.

Add to list

Journal Article
A1
open access

METRO-PD1 : phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors

Nicolas André, Marie Cécile Le Deley, Clémence Léguillette, Alicia Probst, Leen Willems (UGent) , Romain Travers, Isabelle Aerts, Cécile Faure-Conter, Gabriel Revond-Riviere, Victoria Min, et al.

(2024) EUROPEAN JOURNAL OF CANCER. 198.

Academic Bibliography

Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer : a multicenter, single-arm phase 2a study

Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models

CD4+T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy

Lipid nanoparticle encapsulation empowers poly(I:C) to activate cytoplasmic RLRs and thereby increases its adjuvanticity

Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis : post hoc analysis of a large phase 3 trial

Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool

Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial

International Consensus Statement on Allergy and Rhinology : Sinonasal Tumors

Immunotherapy in elderly head and neck cancer patients : a systematic review and meta-analysis

METRO-PD1 : phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors

Contents

Support

Contact